181 related articles for article (PubMed ID: 35671888)
1. Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein.
Hong Y; Guo H; Wei M; Zhang Y; Fang M; Cheng T; Li Z; Ge S; Yao X; Yuan Q; Xia N
J Virol Methods; 2022 Sep; 307():114564. PubMed ID: 35671888
[TBL] [Abstract][Full Text] [Related]
2. Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins.
Díez JM; Romero C; Cruz M; Vandeberg P; Merritt WK; Pradenas E; Trinité B; Blanco J; Clotet B; Willis T; Gajardo R
J Infect Dis; 2022 Mar; 225(6):938-946. PubMed ID: 34693968
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
Zedan HT; Smatti MK; Al-Sadeq DW; Al Khatib HA; Nicolai E; Pieri M; Bernardini S; Hssain AA; Taleb S; Qotba H; Issa K; Abu Raddad LJ; Althani AA; Nasrallah GK; Yassine HM
J Med Virol; 2024 Mar; 96(3):e29527. PubMed ID: 38511514
[TBL] [Abstract][Full Text] [Related]
5. The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein.
Chen X; Rostad CA; Anderson LJ; Sun HY; Lapp SA; Stephens K; Hussaini L; Gibson T; Rouphael N; Anderson EJ
Virology; 2021 Jul; 559():1-9. PubMed ID: 33774551
[TBL] [Abstract][Full Text] [Related]
6. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.
Tso FY; Lidenge SJ; Poppe LK; Peña PB; Privatt SR; Bennett SJ; Ngowi JR; Mwaiselage J; Belshan M; Siedlik JA; Raine MA; Ochoa JB; Garcia-Diaz J; Nossaman B; Buckner L; Roberts WM; Dean MJ; Ochoa AC; West JT; Wood C
PLoS One; 2021; 16(3):e0247640. PubMed ID: 33661923
[TBL] [Abstract][Full Text] [Related]
7. Decay of Fc-dependent antibody functions after mild to moderate COVID-19.
Lee WS; Selva KJ; Davis SK; Wines BD; Reynaldi A; Esterbauer R; Kelly HG; Haycroft ER; Tan HX; Juno JA; Wheatley AK; Hogarth PM; Cromer D; Davenport MP; Chung AW; Kent SJ
Cell Rep Med; 2021 Jun; 2(6):100296. PubMed ID: 33997824
[TBL] [Abstract][Full Text] [Related]
8. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma.
Natarajan H; Crowley AR; Butler SE; Xu S; Weiner JA; Bloch EM; Littlefield K; Wieland-Alter W; Connor RI; Wright PF; Benner SE; Bonny TS; Laeyendecker O; Sullivan D; Shoham S; Quinn TC; Larman HB; Casadevall A; Pekosz A; Redd AD; Tobian AAR; Ackerman ME
mBio; 2021 Apr; 12(2):. PubMed ID: 33879585
[TBL] [Abstract][Full Text] [Related]
9. Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
Motsoeneng BM; Manamela NP; Kaldine H; Kgagudi P; Hermanus T; Ayres F; Makhado Z; Moyo-Gwete T; van der Mescht MA; Abdullah F; Boswell MT; Ueckermann V; Rossouw TM; Madhi SA; Moore PL; Richardson SI
Front Immunol; 2023; 14():1231276. PubMed ID: 37600825
[TBL] [Abstract][Full Text] [Related]
10. Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities.
Wang L; Li C; Li W; Zhao L; Zhao T; Chen L; Li M; Fan J; Li J; Wu C; Chen Y
Emerg Microbes Infect; 2023 Dec; 12(2):2225640. PubMed ID: 37309826
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel reporter gene assay to evaluate antibody-dependent cellular phagocytosis for anti-CD20 therapeutic antibodies.
Liu C; Yu C; Yang Y; Huang J; Yu X; Duan M; Wang L; Wang J
Int Immunopharmacol; 2021 Nov; 100():108112. PubMed ID: 34521023
[TBL] [Abstract][Full Text] [Related]
12. A new flow cytometry assay to measure antibody-dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells.
Beaudoin-Bussières G; Richard J; Prévost J; Goyette G; Finzi A
STAR Protoc; 2021 Dec; 2(4):100851. PubMed ID: 34541555
[TBL] [Abstract][Full Text] [Related]
13. Deciphering Fc-effector functions against SARS-CoV-2.
Beaudoin-Bussières G; Finzi A
Trends Microbiol; 2024 Feb; ():. PubMed ID: 38365562
[TBL] [Abstract][Full Text] [Related]
14. Development of an antibody-dependent cellular cytotoxicity reporter assay for measuring anti-Middle East Respiratory Syndrome antibody bioactivity.
Cao J; Wang L; Yu C; Wang K; Wang W; Yan J; Li Y; Yang Y; Wang X; Wang J
Sci Rep; 2020 Oct; 10(1):16615. PubMed ID: 33024203
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice.
Ma Y; Wang Y; Dong C; Gonzalez GX; Zhu W; Kim J; Wei L; Kang SM; Wang BZ
Small; 2022 Jun; 18(25):e2200836. PubMed ID: 35607768
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients.
Yu Y; Wang M; Zhang X; Li S; Lu Q; Zeng H; Hou H; Li H; Zhang M; Jiang F; Wu J; Ding R; Zhou Z; Liu M; Si W; Zhu T; Li H; Ma J; Gu Y; She G; Li X; Zhang Y; Peng K; Huang W; Liu W; Wang Y
Signal Transduct Target Ther; 2021 Sep; 6(1):346. PubMed ID: 34561414
[TBL] [Abstract][Full Text] [Related]
17. Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210.
Watanabe M; Wallace PK; Keler T; Deo YM; Akewanlop C; Hayes DF
Breast Cancer Res Treat; 1999 Feb; 53(3):199-207. PubMed ID: 10369066
[TBL] [Abstract][Full Text] [Related]
18. Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.
Rieke GJ; van Bremen K; Bischoff J; ToVinh M; Monin MB; Schlabe S; Raabe J; Kaiser KM; Finnemann C; Odainic A; Kudaliyanage A; Latz E; Strassburg CP; Boesecke C; Schmidt SV; Krämer B; Rockstroh JK; Nattermann J
J Infect Dis; 2022 May; 225(10):1688-1693. PubMed ID: 35323975
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J
JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
